Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Nabaparna Bhattacharya

Genenta Extends Collaboration With Anemocyte To Boost Off-The-Shelf Genetic Therapy Production

Gene editing

Genenta Science (NASDAQ:GNTA) shares traded higher in Friday's premarket after the company unveiled an expanded collaboration with biotechnology firm ANEMOCYTE.

The partnership aims to advance the development of off-the-shelf lentiviral vector Plasmid DNA technology.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.